Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Elliot Sigal. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Elliot Sigal telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:ONCE / Spark Therapeutics, Inc. Director 0
US:MJN / Mead Johnson Nutrition Co. Director 0
US:BMY / Bristol-Myers Squibb Company EVP, CSO & President R&D, Director 25,000
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Elliot Sigal. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Elliot Sigal sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -25,786 0 -100.00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -17,203 0 -100.00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -6,000 0 -100.00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -4,000 0 -100.00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Stock Option (Right to Buy)
D - Sale to Issuer -4,000 0 -100.00
2019-12-17 2019-12-17 4 ONCE Spark Therapeutics, Inc.
Common Stock
U - Other -14,214 0 -100.00 114.50 -1,627,503
2019-06-03 2019-05-30 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1,500 0 -100.00
2019-06-03 2019-05-30 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 1,500 14,214 11.80
2018-05-31 2018-05-31 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1,500 0 -100.00
2018-05-31 2018-05-31 4 ONCE Spark Therapeutics, Inc.
Common Stock
M - Exercise 1,500 12,714 13.38
2018-05-31 2018-05-30 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
A - Award 4,000 4,000
2018-05-31 2018-05-30 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 1,500 1,500
2018-04-16 2017-11-28 4 ONCE Spark Therapeutics, Inc.
Common Stock
S - Sale -29 11,214 -0.26 72.43 -2,100 812,230
2018-04-16 2017-10-12 4 ONCE Spark Therapeutics, Inc.
Common Stock
P - Purchase 29 11,243 0.26 90.75 2,632 1,020,302
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
D - Sale to Issuer -1,709 0 -100.00 90.00 -153,810
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -5,180 0 -100.00 90.00 -466,200
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -5,180 0 -100.00 90.00 -466,200
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -2,590 0 -100.00 90.00 -233,100
2017-06-15 2017-06-15 4 MJN Mead Johnson Nutrition Co
Common Stock
D - Sale to Issuer -13,721 0 -100.00 90.00 -1,234,890
2017-06-02 2017-05-31 4 ONCE Spark Therapeutics, Inc.
Restricted Stock Units
A - Award 1,500 1,500
2017-06-02 2017-05-31 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
A - Award 4,000 4,000
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2,373 0 -100.00
2017-03-02 2017-03-01 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2,373 13,721 20.91
2017-03-02 2017-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,709 1,709
2016-06-03 2016-06-01 4 ONCE Spark Therapeutics, Inc.
Stock Option (right to buy)
A - Award 6,000 6,000
2016-03-01 2016-02-29 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise 2,373 2,373
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1,678 0 -100.00
2016-03-01 2016-02-26 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1,678 11,348 17.35
2015-03-03 2015-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -2,146 0 -100.00
2015-03-03 2015-02-28 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 2,146 9,670 28.52
2015-02-27 2015-02-26 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,678 1,678
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -31,559 0 -100.00
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Series B Preferred Stock
A - Award 503 31,559 1.62
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Common Stock
P - Purchase 5,000 11,214 80.46 23.00 115,000 257,922
2015-02-06 2015-02-04 4 ONCE Spark Therapeutics, Inc.
Common Stock
C - Conversion 31,559 31,559
2015-01-29 3 ONCE Spark Therapeutics, Inc.
Common Stock
12,428
2015-01-29 3 ONCE Spark Therapeutics, Inc.
Common Stock
12,428
2014-03-03 2014-02-28 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 2,146 2,146
2014-03-03 2014-02-27 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1,876 0 -100.00
2014-03-03 2014-02-27 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1,876 7,524 33.22
2013-06-05 2013-06-03 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -98,875 25,000 -79.82
2013-06-05 2013-06-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -83,647 148,221 -36.08 48.18 -4,030,112 7,141,288
2013-06-05 2013-06-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 98,875 231,868 74.35 27.01 2,670,614 6,262,755
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -50,000 0 -100.00
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -120,625 123,875 -49.34
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -143,521 132,993 -51.90 47.23 -6,778,497 6,281,259
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 50,000 276,514 22.07 24.74 1,237,000 6,840,956
2013-05-31 2013-05-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 120,625 226,514 113.92 27.01 3,258,081 6,118,143
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -202,405 50,000 -80.19
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -103,500 0 -100.00
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -459 9,091 -4.81 39.65 -18,199 360,458
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -919 18,180 -4.81 39.65 -36,438 720,837
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -919 18,180 -4.81 39.65 -36,438 720,837
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -175,143 105,889 -62.32 39.61 -6,937,414 4,194,263
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -90,234 281,032 -24.30 39.61 -3,574,169 11,131,678
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -88,132 371,266 -19.18 39.63 -3,492,671 14,713,272
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 103,500 459,398 29.08 25.45 2,634,075 11,691,679
2013-05-01 2013-04-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 202,405 355,898 131.87 24.74 5,007,500 8,804,917
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -36,503 252,405 -12.63
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -11,092 288,908 -3.70
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -25,795 0 -100.00
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -9,157 9,550 -48.95 39.97 -366,005 381,714
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -18,313 19,099 -48.95 39.97 -731,971 763,387
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -18,313 19,099 -48.95 39.97 -731,971 763,387
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -41,868 153,493 -21.43 39.92 -1,671,371 6,127,441
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -31,594 195,361 -13.92 39.90 -1,260,601 7,794,904
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -21,856 226,955 -8.78 39.90 -872,054 9,055,504
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -9,600 248,811 -3.72 40.00 -384,000 9,952,440
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 11,092 258,411 4.48 24.74 274,416 6,393,088
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 25,795 247,319 11.64 22.73 586,320 5,621,561
2013-05-01 2013-04-29 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 36,503 221,524 19.73 24.74 903,084 5,480,504
2013-03-11 2013-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 29,630 29,630
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 845 22,011 3.99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 21,166 21,166
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 2,466 64,243 3.99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 27,866 61,777 82.17
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -99,812 0 -100.00
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 3,832 99,812 3.99
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 29,007 95,980 43.31
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -8,801 26,406 -25.00
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -12,062 35,491 -25.37
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -11,715 47,553 -19.77
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -51,754 185,021 -21.86 37.53 -1,942,328 6,943,838
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -9,343 236,775 -3.80 37.53 -350,643 8,886,166
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -8,748 246,118 -3.43 37.53 -328,312 9,236,809
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -5,194 254,866 -2.00 37.53 -194,931 9,565,121
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 1,216 260,060 0.47
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 5,156 258,844 2.03
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 5,957 253,688 2.40
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 8,801 247,731 3.68
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 11,715 238,930 5.16
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 12,062 227,215 5.61
2013-03-11 2013-03-07 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 99,812 215,153 86.54
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -7,453 0 -100.00
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3,865 115,341 -3.24 36.94 -142,773 4,260,697
2013-03-05 2013-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 7,453 119,206 6.67
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -46,365 46,367 -50.00
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -24,041 111,753 -17.70 37.15 -893,123 4,151,624
2013-03-05 2013-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 46,365 135,794 51.85
2013-03-04 2013-03-02 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
M - Exercise -1,789 0 -100.00
2013-03-04 2013-03-02 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1,789 5,648 46.36
2013-03-04 2013-02-27 4 MJN Mead Johnson Nutrition Co
Restricted Stock Unit (RSU)
A - Award 1,876 1,876
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Option (right to buy)
M - Exercise -48,333 0 -100.00
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -70,000 25,795 -73.07
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Executive Option (right to buy)
M - Exercise -147,749 0 -100.00
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -224,705 89,429 -71.53 36.79 -8,266,897 3,290,093
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 48,333 314,134 18.18 28.11 1,358,641 8,830,307
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 70,000 265,801 35.75 22.73 1,591,100 6,041,657
2013-02-11 2013-02-08 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 147,749 195,801 307.48 17.51 2,587,085 3,428,476
2012-12-13 2012-12-11 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -62,903 37,412 -62.71 33.00 -2,075,799 1,234,596
2012-12-13 2012-12-11 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -62,903 37,412 -62.71 33.00 -2,075,799 1,234,596
2012-12-13 2012-12-11 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -31,451 18,707 -62.70 33.00 -1,037,883 617,331
2012-12-13 2012-11-27 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
G - Gift 100,315 100,315
2012-12-13 2012-11-27 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
G - Gift 100,315 100,315
2012-12-13 2012-11-27 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
G - Gift -200,630 50,158 -80.00
2012-12-03 2012-11-27 4 MJN Mead Johnson Nutrition Co
Common Stock
G - Gift 5,180 5,180
2012-12-03 2012-11-27 4 MJN Mead Johnson Nutrition Co
Common Stock
G - Gift 5,180 5,180
2012-12-03 2012-11-27 4 MJN Mead Johnson Nutrition Co
Common Stock
G - Gift -10,360 2,590 -80.00
2012-09-14 2012-01-03 4 MJN Mead Johnson Nutrition Co
Common Stock
J - Other -4 0 -100.00 71.35 -282
2012-09-14 2012-01-03 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 4 71.35 282 282
2012-09-14 2011-12-20 4 MJN Mead Johnson Nutrition Co
Common Stock
J - Other -1,083 0 -100.00 74.19 -80,361
2012-09-14 2011-10-03 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1,083 0.37 68.11 275 73,779
2012-09-14 2011-07-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1,079 0.38 69.04 282 74,508
2012-09-14 2011-04-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 5 1,075 0.45 58.33 279 62,711
2012-09-14 2011-01-03 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1,070 0.36 62.30 238 66,681
2012-09-14 2010-10-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1,067 0.40 56.25 240 59,991
2012-09-14 2010-07-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 5 1,062 0.45 50.53 241 53,675
2012-09-14 2010-04-01 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 5 1,057 0.43 52.90 241 55,940
2012-09-14 2010-01-15 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 4 1,053 0.42 46.81 208 49,287
2012-09-14 2009-12-29 4 MJN Mead Johnson Nutrition Co
Common Stock
P - Purchase 9 1,048 0.84 44.58 389 46,741
2012-09-07 2012-09-05 4 MJN Mead Johnson Nutrition Co
Common Stock
J - Other -12,950 16,809 -43.52
2012-09-07 2012-09-05 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -250,788 298,840 -45.63
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -6,875 0 -100.00
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 1,457 33,911 4.49
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 32,454 32,454
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -78,955 66,973 -54.11
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
J - Other 2,879 145,928 2.01
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 28,152 143,049 24.50
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 33,783 114,897 41.65
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 35,207 35,207
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -36,597 298,840 -10.91 32.33 -1,183,181 9,661,497
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3,187 335,437 -0.94 32.33 -103,036 10,844,678
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 6,875 338,624 2.07
2012-03-08 2012-03-06 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 78,955 331,749 31.23
2012-03-06 2012-03-02 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
M - Exercise -1,699 1,789 -48.71 78.26 -132,964 140,007
2012-03-06 2012-03-02 4 MJN Mead Johnson Nutrition Co
Restricted Stock Units
A - Award 1,789 3,488 105.30
2012-03-06 2012-03-02 4 MJN Mead Johnson Nutrition Co
Common Stock
M - Exercise 1,699 16,809 11.24 78.26 132,964 1,315,472
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -7,453 7,453 -50.00
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -3,455 252,794 -1.35 32.59 -112,598 8,238,556
2012-03-05 2012-03-04 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 7,453 256,249 3.00
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -46,365 92,732 -33.33
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -21,491 248,796 -7.95 32.59 -700,392 8,108,262
2012-03-05 2012-03-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 46,365 270,287 20.71
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -12,062 59,268 -16.91
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -7,383 223,922 -3.19 32.59 -240,612 7,297,618
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 3,866 231,305 1.70
2012-03-05 2012-03-02 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 12,062 227,439 5.60
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -11,714 71,330 -14.11
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -5,412 215,377 -2.45 32.64 -176,648 7,029,905
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 3,173 220,789 1.46
2012-03-05 2012-03-01 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 11,714 217,616 5.69
2011-12-29 2010-03-06 4/A BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -6,875 13,750 -33.33
2009-03-12 3 MJN Mead Johnson Nutrition Co
Common Stock
5,000
2003-08-04 2003-08-01 4 (BMY) BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,219 75,024 -1.60
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)